Results 101 to 110 of about 4,421 (195)

No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study [PDF]

Aims/hypothesis: It is generally recommended to reduce basal insulin doses after exercise to reduce the risk of post-exercise nocturnal hypoglycaemia.
de Galan, BE, Drenthen, LCA, Tack, CJ, Ajie, M, Abbink, EJ, Rodwell, L, Thijssen, DHJ   +6 more
core   +1 more source

[Basal insulin degludec - liraglutide fixed ratio combination (Xultophy®)].

, 2018
Xultophy® (IDegLira) is a fixed ratio combination of basal insulin degludec and glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide. Insulin degludec is characterized by an original mode of prolonged and continuous insulin diffusion after its ...
Scheen, A.J., Mathieu, C.
core  

Insulin Efsitora Versus Degludec in Adults with Type 2 Diabetes Using Basal Insulin: QWINT-3 Japan Subgroup Analysis. [PDF]

Diabetes Ther
Jinnouchi H, Inoue M, Takita Y, Nasu R, Threlkeld R.   +4 more
europepmc   +1 more source

Efficacy and safety of insulin icodec compared with insulin efsitora in patients with type 2 diabetes: a systematic review and network meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Li J, Wen J, Zheng H, Quan C, Bi J, Yang Y, Zhang J, Shen Y.   +7 more
europepmc   +1 more source

Projecting the Long-Term Cost-Effectiveness of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogs in Italy Using the Prime T2D Model. [PDF]

Diabetes Obes Metab
Malkin SJP, Kandalam S, Guareschi G, D'Angiolella LS, Hunt B.   +4 more
europepmc   +1 more source

Efficacy and Safety of Insulin Efsitora Versus Degludec in Adults with Type 2 Diabetes Who Are Insulin-Naïve: Japan Subgroup Analysis of QWINT-2. [PDF]

Diabetes Ther
Kiyosue A, Inoue M, Takita Y, Nasu R, Watada H.   +4 more
europepmc   +1 more source

Incretin-based injectable strategies versus intensified insulin for treatment intensification and simplification in type 2 diabetes: a systematic review and meta-analysis. [PDF]

J Diabetes Metab Disord
Mahmood T, Myrtziou I, Kanakis I.
europepmc   +1 more source

A Novel Approach to Managing "Double Diabetes" in a Pediatric Patient on Insulin Pump Therapy: An Off-Label Use of a Fixed-Ratio Insulin Degludec/Liraglutide Combination. [PDF]

Cureus
Almoallem B, Thalange NK.
europepmc   +1 more source

Intra-Subject Variability in Pharmacokinetics and Pharmacodynamics of Basal Insulin at Two Single-Dose Levels: Findings from Euglycemic Glucose Clamp Bioequivalence Studies of Insulin Degludec. [PDF]

Pharmaceutics
Liu H, Li T, Chen X, Yu H, Men Y, Tan H, Li J, Yu Y.   +7 more
europepmc   +1 more source

Once-Weekly Subcutaneous Insulin Efsitora for the Management of Diabetes Mellitus: A Systematic Review and Meta-Analysis Study. [PDF]

Medeni Med J
Copur S, Mizrak B, Ozbek L, Ucku D, Batman A, Gaipov A, Covic A, Raalte DV, Kanbay M.   +8 more
europepmc   +1 more source